Assumptions, model disagreement, and rethink triggers, updated weekly before your PM, risk, or IC discussion. Currently accepting one macro thesis and one AI-economy thesis for July.
4-model average
building category history
loading
40pt spread
Consensus sits at 47% across the four models and is — (loading). Models are diverging at a 40pt spread, so the average conceals live disagreement worth inspecting below. Category confidence is LOW (building category history).
Confidence reflects category-level track record. Stability tracks estimate movement. Models shows whether the four agree.
Loading belief trajectory...
The growing integration of AI in research and publishing suggests increasing scrutiny over undisclosed AI contributions. As of 2023, numerous institutions are already implementing guidelines to disclose AI usage in research, which could lead journals to adopt stricter retraction policies if such disclosures are not adhered to. Moreover, in 2022, several high-profile retractions occurred due to issues surrounding authorship and contribution, setting a precedent for future actions against undisclosed AI use.
The rapid advancement and adoption of AI in research writing, coupled with increasing scrutiny from publishers and ethical bodies, makes widespread undisclosed AI-generated content a growing concern. The sheer volume of research published annually means that even a small percentage of undisclosed AI use could easily surpass 20 retractions by 2029. As detection tools improve and editorial policies become more stringent, instances of flagged content are likely to increase.
The medical publishing ecosystem is experiencing unprecedented scrutiny of AI usage following high-profile retractions (e.g., Nature's 2023-2024 AI-related retractions, multiple ChatGPT-detected papers), but we lack clear evidence of systematic undisclosed AI generation at scale sufficient for 20+ retractions in a single journal-year. Historical retraction rates for US medical journals average 1-3 papers annually per major journal, so reaching 20+ for a single cause would represent a 6-20x increase above baseline. However, the combination of: (1) increasing AI adoption in manuscript preparation, (2) journals' strengthening detection capabilities, (3) tightening disclosure policies, and (4) 5 years remaining until 2029 for a single egregious case to emerge, makes this plausible but not highly probable. The probability increases if detection improves faster than author compliance, but decreases if journals successfully implement preventive measures and standardize disclosure requirements.
AI text-generation tools have seen exponential adoption since GPT-3.5 (Nov 2022), with 2023-2024 surveys showing 25-40% of biomedical researchers using LLMs for drafting; journals already retracted 12 papers in 2024 solely for undisclosed AI use (e.g., Frontiers, Cureus cases), and the current 3-6 month detection lag plus 18-month average retraction timeline implies at least one high-volume incident by 2028. Structural drivers include COPE’s 2023 AI disclosure mandate, NIH and NSF grant language requiring AI acknowledgment, and the 4-6% annual rise in total retractions (Retraction Watch 2018-2023 data) that amplifies the numerator.